Abstract
Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.Last year, we inaugurated a series of occasional research and scholarly review articles with the intent of capturing some of the progress now being made in the scientific understanding, diagnosis, treatment, and prevention of Alzheimer's disease (AD). In this issue of The Journal of Clinical Psychiatry, Andreas Papassotiropoulos, Michael Fountoulakis, Travis Dunckley, Dietrich Stephan, and I consider the progress now being made in the genetic, transcriptomic, and proteomic study of AD.Twin studies suggest that about 75% of the risk for late-onset AD may be attributable to heritable risk factors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
